Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau

NCT06637267 is registered in ClinicalTrials.gov with Kantonsspital Aarau as lead sponsor.

NCT NCT06637267
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06637267 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Evaluation of Proclarix® Test to Improve Risk Stratification in Men Scheduled for MpMRI and Prostate Biopsy in Cantonal Hospital Aarau
Lead sponsor
Kantonsspital Aarau
Phase
Observational
Overall status
Recruiting
Start date
August 24, 2022
Completion date
December 30, 2026
Enrollment
480 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate cancer